Consonance Capital Management LP 13F Holdings · last filed Q3 2022
Consonance Capital Management LP reported 2 securities worth $7.28M in its SEC 13F filing for Q3 2022 (period ended 2022-09-30). Top holdings: SRZN (97.05%), SRZNW (2.95%), CMPX (0.00%). Among its top 25 positions this quarter: 5 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SRZN | SURROZEN INC | $7.1M | 97.05% | 3.5M | Hold |
| 2 | SRZNW | SURROZEN INC | $215,000 | 2.95% | 1.2M | Hold |
| 3 | CMPX | COMPASS THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 4 | GMED | GLOBUS MED INC | $0 | 0.00% | 0 | Exited |
| 5 | SLN | SILENCE THERAPEUTICS PLC | $0 | 0.00% | 0 | Exited |
| 6 | TNDM | TANDEM DIABETES CARE INC | $0 | 0.00% | 0 | Exited |
| 7 | UTHR | UNITED THERAPEUTICS CORP DEL | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2022-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR